RE: Prostate cancer Therapeutics Market value $18b24 Sep 2020 21:54
Gracey, Val 401 is why I invested years ago. By the time the patient have no other options we can test our Val 401 compound. Cemo is so harsh they want to give up. Val 401 is kinder and the patient may be mentally able to accept not only our drugs but any other cancer life saving drugs out their. God bless them.